Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) EV to EBITDA (2025)

Updated

Evofem Biosciences' EV to EBITDA came in at 0.18 for Q4 2025.

Analysis

Evofem Biosciences (EVFM) EV to EBITDA (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.18
API Access

Evofem Biosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=EVFM&period=max&api_key=YOUR_API_KEY